Standout Papers
- Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results (2002)
- Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study (2011)
- Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee. (1999)
Immediate Impact
9 by Nobel laureates 2 from Science/Nature 76 standout
Citing Papers
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of Chris Twelves being referenced
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chris Twelves | 6387 | 2208 | 1683 | 2110 | 182 | 9.5k | |
| Andrew D. Seidman | 7951 | 2423 | 2143 | 2133 | 206 | 10.8k | |
| Linda T. Vahdat | 7383 | 2015 | 2673 | 3569 | 236 | 11.2k | |
| Haralabos P. Kalofonos | 5918 | 2053 | 1245 | 2612 | 381 | 10.1k | |
| Román Pérez-Soler | 5515 | 3074 | 873 | 4201 | 213 | 9.8k | |
| Joyce O’Shaughnessy | 6829 | 2692 | 2978 | 2102 | 237 | 9.2k | |
| Nuhad K. Ibrahim | 6209 | 1726 | 3866 | 2753 | 143 | 9.8k | |
| Ross C. Donehower | 9989 | 2687 | 1567 | 5607 | 220 | 15.8k | |
| G. Milano | 7643 | 3057 | 1514 | 3973 | 390 | 12.0k | |
| Joyce O’Shaughnessy | 10008 | 3769 | 4254 | 2924 | 341 | 13.6k | |
| Dominic T. Moore | 3442 | 2009 | 2750 | 2633 | 125 | 7.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...